nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—nerve—alcohol dependence	0.0247	0.0687	CbGeAlD
Lithium—GSK3B—nerve—alcohol dependence	0.0214	0.0595	CbGeAlD
Lithium—Psychomotor retardation—Citalopram—alcohol dependence	0.0163	0.0389	CcSEcCtD
Lithium—GRIA3—Unblocking of NMDA receptor, glutamate binding and activation—GRIN2B—alcohol dependence	0.0154	0.0691	CbGpPWpGaD
Lithium—Optic neuritis—Disulfiram—alcohol dependence	0.013	0.0311	CcSEcCtD
Lithium—Psoriasis flare-up—Citalopram—alcohol dependence	0.0129	0.0309	CcSEcCtD
Lithium—IMPA1—forebrain—alcohol dependence	0.012	0.0335	CbGeAlD
Lithium—Goitre—Acamprosate—alcohol dependence	0.011	0.0264	CcSEcCtD
Lithium—GRIA3—forebrain—alcohol dependence	0.0102	0.0285	CbGeAlD
Lithium—IMPA1—cardiovascular system—alcohol dependence	0.0102	0.0283	CbGeAlD
Lithium—GRIA3—Hypothetical Network for Drug Addiction—DRD4—alcohol dependence	0.00963	0.0433	CbGpPWpGaD
Lithium—GRIA3—adrenal cortex—alcohol dependence	0.00948	0.0264	CbGeAlD
Lithium—GRIA3—Hypothetical Network for Drug Addiction—GRIN2B—alcohol dependence	0.00927	0.0416	CbGpPWpGaD
Lithium—IMPA1—gonad—alcohol dependence	0.00923	0.0257	CbGeAlD
Lithium—GRIA3—Hypothetical Network for Drug Addiction—DRD2—alcohol dependence	0.00897	0.0403	CbGpPWpGaD
Lithium—GSK3B—forebrain—alcohol dependence	0.00886	0.0247	CbGeAlD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ6—alcohol dependence	0.00806	0.0362	CbGpPWpGaD
Lithium—IMPA1—blood—alcohol dependence	0.00804	0.0224	CbGeAlD
Lithium—Chest tightness—Naltrexone—alcohol dependence	0.00795	0.019	CcSEcCtD
Lithium—Peripheral coldness—Naltrexone—alcohol dependence	0.00783	0.0187	CcSEcCtD
Lithium—GSK3A—forebrain—alcohol dependence	0.0077	0.0214	CbGeAlD
Lithium—GRIA3—Activation of NMDA receptor upon glutamate binding and postsynaptic events—GRIN2B—alcohol dependence	0.0076	0.0342	CbGpPWpGaD
Lithium—GSK3B—cardiovascular system—alcohol dependence	0.00749	0.0208	CbGeAlD
Lithium—Taste metallic—Citalopram—alcohol dependence	0.00743	0.0178	CcSEcCtD
Lithium—IMPA2—pancreas—alcohol dependence	0.00742	0.0207	CbGeAlD
Lithium—GSK3A—adrenal cortex—alcohol dependence	0.00714	0.0199	CbGeAlD
Lithium—Sexual dysfunction—Acamprosate—alcohol dependence	0.00703	0.0168	CcSEcCtD
Lithium—IMPA1—endocrine gland—alcohol dependence	0.00698	0.0194	CbGeAlD
Lithium—GSK3B—gonad—alcohol dependence	0.0068	0.0189	CbGeAlD
Lithium—GRIA3—midbrain—alcohol dependence	0.00675	0.0188	CbGeAlD
Lithium—IMPA1—testis—alcohol dependence	0.00665	0.0185	CbGeAlD
Lithium—Sexual dysfunction—Naltrexone—alcohol dependence	0.00665	0.0159	CcSEcCtD
Lithium—Goitre—Citalopram—alcohol dependence	0.00661	0.0158	CcSEcCtD
Lithium—IMPA1—nervous system—alcohol dependence	0.00653	0.0182	CbGeAlD
Lithium—GSK3A—cardiovascular system—alcohol dependence	0.00651	0.0181	CbGeAlD
Lithium—Dental caries—Citalopram—alcohol dependence	0.00634	0.0152	CcSEcCtD
Lithium—IMPA2—digestive system—alcohol dependence	0.00634	0.0176	CbGeAlD
Lithium—GSK3A—pancreas—alcohol dependence	0.00633	0.0176	CbGeAlD
Lithium—IMPA1—liver—alcohol dependence	0.00629	0.0175	CbGeAlD
Lithium—IMPA1—central nervous system—alcohol dependence	0.00629	0.0175	CbGeAlD
Lithium—Psoriasis—Acamprosate—alcohol dependence	0.00627	0.015	CcSEcCtD
Lithium—GSK3B—digestive system—alcohol dependence	0.00622	0.0173	CbGeAlD
Lithium—Hypothyroidism—Acamprosate—alcohol dependence	0.00614	0.0147	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.00606	0.0272	CbGpPWpGaD
Lithium—IMPA2—blood—alcohol dependence	0.00604	0.0168	CbGeAlD
Lithium—Hyperthyroidism—Citalopram—alcohol dependence	0.00597	0.0143	CcSEcCtD
Lithium—GSK3B—blood—alcohol dependence	0.00592	0.0165	CbGeAlD
Lithium—GSK3A—gonad—alcohol dependence	0.00591	0.0164	CbGeAlD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB1—alcohol dependence	0.00583	0.0262	CbGpPWpGaD
Lithium—GRIA3—testis—alcohol dependence	0.00566	0.0157	CbGeAlD
Lithium—GRIA3—nervous system—alcohol dependence	0.00555	0.0155	CbGeAlD
Lithium—GSK3B—Reelin signaling pathway—GRIN2B—alcohol dependence	0.00546	0.0245	CbGpPWpGaD
Lithium—GSK3A—digestive system—alcohol dependence	0.00541	0.015	CbGeAlD
Lithium—GRIA3—liver—alcohol dependence	0.00535	0.0149	CbGeAlD
Lithium—GRIA3—central nervous system—alcohol dependence	0.00535	0.0149	CbGeAlD
Lithium—GRIA3—cerebellum—alcohol dependence	0.00523	0.0145	CbGeAlD
Lithium—GSK3A—blood—alcohol dependence	0.00515	0.0143	CbGeAlD
Lithium—GSK3B—endocrine gland—alcohol dependence	0.00514	0.0143	CbGeAlD
Lithium—GSK3A—midbrain—alcohol dependence	0.00509	0.0142	CbGeAlD
Lithium—Chest tightness—Citalopram—alcohol dependence	0.00504	0.012	CcSEcCtD
Lithium—IMPA2—testis—alcohol dependence	0.00499	0.0139	CbGeAlD
Lithium—IMPA1—brain—alcohol dependence	0.00499	0.0139	CbGeAlD
Lithium—Peripheral coldness—Citalopram—alcohol dependence	0.00496	0.0119	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—alcohol dependence	0.00495	0.0223	CbGpPWpGaD
Lithium—GSK3B—testis—alcohol dependence	0.0049	0.0136	CbGeAlD
Lithium—Muscle contractions involuntary—Citalopram—alcohol dependence	0.00489	0.0117	CcSEcCtD
Lithium—GSK3B—nervous system—alcohol dependence	0.00481	0.0134	CbGeAlD
Lithium—IMPA2—liver—alcohol dependence	0.00472	0.0131	CbGeAlD
Lithium—GRIA3—Neuronal System—KCNJ6—alcohol dependence	0.00464	0.0209	CbGpPWpGaD
Lithium—GSK3B—liver—alcohol dependence	0.00463	0.0129	CbGeAlD
Lithium—GSK3B—central nervous system—alcohol dependence	0.00463	0.0129	CbGeAlD
Lithium—Erectile dysfunction—Disulfiram—alcohol dependence	0.00462	0.011	CcSEcCtD
Lithium—GSK3B—cerebellum—alcohol dependence	0.00452	0.0126	CbGeAlD
Lithium—Drowsiness—Disulfiram—alcohol dependence	0.00447	0.0107	CcSEcCtD
Lithium—GSK3A—endocrine gland—alcohol dependence	0.00447	0.0124	CbGeAlD
Lithium—GSK3B—Melatonin metabolism and effects—MAOA—alcohol dependence	0.00442	0.0199	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.00438	0.0197	CbGpPWpGaD
Lithium—GSK3A—testis—alcohol dependence	0.00426	0.0119	CbGeAlD
Lithium—GRIA3—brain—alcohol dependence	0.00424	0.0118	CbGeAlD
Lithium—Sexual dysfunction—Citalopram—alcohol dependence	0.00421	0.0101	CcSEcCtD
Lithium—Chest discomfort—Naltrexone—alcohol dependence	0.00421	0.0101	CcSEcCtD
Lithium—GSK3A—nervous system—alcohol dependence	0.00418	0.0116	CbGeAlD
Lithium—GSK3A—liver—alcohol dependence	0.00403	0.0112	CbGeAlD
Lithium—GSK3A—central nervous system—alcohol dependence	0.00402	0.0112	CbGeAlD
Lithium—Muscle twitching—Acamprosate—alcohol dependence	0.00401	0.00959	CcSEcCtD
Lithium—GSK3A—cerebellum—alcohol dependence	0.00393	0.0109	CbGeAlD
Lithium—Salivary hypersecretion—Acamprosate—alcohol dependence	0.00383	0.00915	CcSEcCtD
Lithium—Urinary incontinence—Acamprosate—alcohol dependence	0.0038	0.0091	CcSEcCtD
Lithium—Muscle twitching—Naltrexone—alcohol dependence	0.0038	0.00908	CcSEcCtD
Lithium—Psoriasis—Citalopram—alcohol dependence	0.00376	0.00898	CcSEcCtD
Lithium—Folliculitis—Citalopram—alcohol dependence	0.00376	0.00898	CcSEcCtD
Lithium—IMPA2—brain—alcohol dependence	0.00375	0.0104	CbGeAlD
Lithium—GRIA3—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.00372	0.0167	CbGpPWpGaD
Lithium—Hypothyroidism—Citalopram—alcohol dependence	0.00368	0.0088	CcSEcCtD
Lithium—GSK3B—brain—alcohol dependence	0.00368	0.0102	CbGeAlD
Lithium—Urine output increased—Acamprosate—alcohol dependence	0.00356	0.00852	CcSEcCtD
Lithium—GRIA3—Neuronal System—GABRB1—alcohol dependence	0.00336	0.0151	CbGpPWpGaD
Lithium—Nystagmus—Citalopram—alcohol dependence	0.00331	0.00791	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—CRHR1—alcohol dependence	0.00327	0.0147	CbGpPWpGaD
Lithium—Polyuria—Acamprosate—alcohol dependence	0.00326	0.00779	CcSEcCtD
Lithium—GSK3A—brain—alcohol dependence	0.0032	0.00889	CbGeAlD
Lithium—Stupor—Citalopram—alcohol dependence	0.00316	0.00756	CcSEcCtD
Lithium—Extrapyramidal disorder—Citalopram—alcohol dependence	0.00314	0.0075	CcSEcCtD
Lithium—Scotoma—Citalopram—alcohol dependence	0.00311	0.00744	CcSEcCtD
Lithium—Swelling—Naltrexone—alcohol dependence	0.00307	0.00733	CcSEcCtD
Lithium—IMPA2—Metabolism—ADH6—alcohol dependence	0.00301	0.0135	CbGpPWpGaD
Lithium—Memory impairment—Citalopram—alcohol dependence	0.00301	0.00719	CcSEcCtD
Lithium—Thirst—Acamprosate—alcohol dependence	0.003	0.00719	CcSEcCtD
Lithium—GRIA3—Neuronal System—GABRA2—alcohol dependence	0.00285	0.0128	CbGpPWpGaD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—alcohol dependence	0.00285	0.0128	CbGpPWpGaD
Lithium—Thirst—Naltrexone—alcohol dependence	0.00284	0.0068	CcSEcCtD
Lithium—GRIA3—BDNF signaling pathway—GRIN2B—alcohol dependence	0.00278	0.0125	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—CNR1—alcohol dependence	0.00276	0.0124	CbGpPWpGaD
Lithium—Lethargy—Naltrexone—alcohol dependence	0.00276	0.0066	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.00271	0.0122	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ADH6—alcohol dependence	0.00269	0.0121	CbGpPWpGaD
Lithium—Chest discomfort—Citalopram—alcohol dependence	0.00267	0.00638	CcSEcCtD
Lithium—Dry skin—Acamprosate—alcohol dependence	0.00262	0.00627	CcSEcCtD
Lithium—Oliguria—Citalopram—alcohol dependence	0.00256	0.00613	CcSEcCtD
Lithium—Somnolence—Disulfiram—alcohol dependence	0.00254	0.00607	CcSEcCtD
Lithium—Gastritis—Acamprosate—alcohol dependence	0.00253	0.00605	CcSEcCtD
Lithium—Dehydration—Naltrexone—alcohol dependence	0.00252	0.00602	CcSEcCtD
Lithium—Leukocytosis—Citalopram—alcohol dependence	0.00251	0.00601	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—CRH—alcohol dependence	0.00251	0.0113	CbGpPWpGaD
Lithium—Dysarthria—Citalopram—alcohol dependence	0.0025	0.00597	CcSEcCtD
Lithium—IMPA2—Metabolism—ADH1A—alcohol dependence	0.0025	0.0112	CbGpPWpGaD
Lithium—Fatigue—Disulfiram—alcohol dependence	0.00246	0.00588	CcSEcCtD
Lithium—Muscle twitching—Citalopram—alcohol dependence	0.0024	0.00575	CcSEcCtD
Lithium—Coordination abnormal—Citalopram—alcohol dependence	0.0024	0.00575	CcSEcCtD
Lithium—GSK3B—Alzheimers Disease—GRIN2B—alcohol dependence	0.00238	0.0107	CbGpPWpGaD
Lithium—Salivary hypersecretion—Citalopram—alcohol dependence	0.00229	0.00548	CcSEcCtD
Lithium—Urinary incontinence—Citalopram—alcohol dependence	0.00228	0.00545	CcSEcCtD
Lithium—Depressed level of consciousness—Citalopram—alcohol dependence	0.00228	0.00545	CcSEcCtD
Lithium—Erectile dysfunction—Acamprosate—alcohol dependence	0.00228	0.00544	CcSEcCtD
Lithium—Weight increased—Acamprosate—alcohol dependence	0.00225	0.00538	CcSEcCtD
Lithium—Weight decreased—Acamprosate—alcohol dependence	0.00224	0.00535	CcSEcCtD
Lithium—Hyperglycaemia—Acamprosate—alcohol dependence	0.00223	0.00533	CcSEcCtD
Lithium—IMPA1—Metabolism—ADH1A—alcohol dependence	0.00223	0.01	CbGpPWpGaD
Lithium—Coma—Citalopram—alcohol dependence	0.00216	0.00516	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.00214	0.00961	CbGpPWpGaD
Lithium—Urine output increased—Citalopram—alcohol dependence	0.00214	0.00511	CcSEcCtD
Lithium—Weight increased—Naltrexone—alcohol dependence	0.00213	0.00509	CcSEcCtD
Lithium—IMPA2—Metabolism—ADH4—alcohol dependence	0.00212	0.00954	CbGpPWpGaD
Lithium—Weight decreased—Naltrexone—alcohol dependence	0.00212	0.00506	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.00211	0.00947	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—ALDH2—alcohol dependence	0.00207	0.00932	CbGpPWpGaD
Lithium—Hypertonia—Citalopram—alcohol dependence	0.00207	0.00495	CcSEcCtD
Lithium—Asthenia—Disulfiram—alcohol dependence	0.00205	0.0049	CcSEcCtD
Lithium—Hallucination—Acamprosate—alcohol dependence	0.00197	0.00471	CcSEcCtD
Lithium—Polyuria—Citalopram—alcohol dependence	0.00195	0.00467	CcSEcCtD
Lithium—GSK3A—FOXM1 transcription factor network—EP300—alcohol dependence	0.00192	0.00863	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ADH4—alcohol dependence	0.00189	0.0085	CbGpPWpGaD
Lithium—Dizziness—Disulfiram—alcohol dependence	0.00189	0.00451	CcSEcCtD
Lithium—Hallucination—Naltrexone—alcohol dependence	0.00186	0.00445	CcSEcCtD
Lithium—Tinnitus—Acamprosate—alcohol dependence	0.00184	0.00441	CcSEcCtD
Lithium—IMPA1—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.00183	0.00823	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ADH7—alcohol dependence	0.00181	0.00811	CbGpPWpGaD
Lithium—Thirst—Citalopram—alcohol dependence	0.0018	0.00431	CcSEcCtD
Lithium—Rash—Disulfiram—alcohol dependence	0.0018	0.0043	CcSEcCtD
Lithium—Headache—Disulfiram—alcohol dependence	0.00179	0.00427	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.00178	0.008	CbGpPWpGaD
Lithium—Lethargy—Citalopram—alcohol dependence	0.00175	0.00418	CcSEcCtD
Lithium—Alopecia—Acamprosate—alcohol dependence	0.00175	0.00418	CcSEcCtD
Lithium—Tinnitus—Naltrexone—alcohol dependence	0.00175	0.00417	CcSEcCtD
Lithium—IMPA2—Metabolism—GGT2—alcohol dependence	0.00173	0.00778	CbGpPWpGaD
Lithium—Flatulence—Acamprosate—alcohol dependence	0.0017	0.00406	CcSEcCtD
Lithium—Dysgeusia—Acamprosate—alcohol dependence	0.00169	0.00403	CcSEcCtD
Lithium—Alopecia—Naltrexone—alcohol dependence	0.00165	0.00395	CcSEcCtD
Lithium—GRIA3—Neuronal System—GRIN2B—alcohol dependence	0.00164	0.00737	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—SLC6A3—alcohol dependence	0.00162	0.00726	CbGpPWpGaD
Lithium—Tremor—Acamprosate—alcohol dependence	0.00161	0.00386	CcSEcCtD
Lithium—Ataxia—Citalopram—alcohol dependence	0.00161	0.00385	CcSEcCtD
Lithium—IMPA1—Metabolism—ADH7—alcohol dependence	0.00161	0.00723	CbGpPWpGaD
Lithium—Flatulence—Naltrexone—alcohol dependence	0.00161	0.00384	CcSEcCtD
Lithium—Dysgeusia—Naltrexone—alcohol dependence	0.0016	0.00382	CcSEcCtD
Lithium—Dehydration—Citalopram—alcohol dependence	0.00159	0.00381	CcSEcCtD
Lithium—IMPA2—Metabolism—ADH1B—alcohol dependence	0.00158	0.00711	CbGpPWpGaD
Lithium—Agitation—Acamprosate—alcohol dependence	0.00158	0.00378	CcSEcCtD
Lithium—Angioedema—Acamprosate—alcohol dependence	0.00157	0.00376	CcSEcCtD
Lithium—Dry skin—Citalopram—alcohol dependence	0.00157	0.00376	CcSEcCtD
Lithium—Vertigo—Acamprosate—alcohol dependence	0.00155	0.0037	CcSEcCtD
Lithium—Syncope—Acamprosate—alcohol dependence	0.00154	0.00369	CcSEcCtD
Lithium—IMPA1—Metabolism—GGT2—alcohol dependence	0.00154	0.00693	CbGpPWpGaD
Lithium—GSK3B—Cellular response to heat stress—EP300—alcohol dependence	0.00154	0.00691	CbGpPWpGaD
Lithium—Vision blurred—Naltrexone—alcohol dependence	0.00154	0.00367	CcSEcCtD
Lithium—Tremor—Naltrexone—alcohol dependence	0.00153	0.00365	CcSEcCtD
Lithium—Gastritis—Citalopram—alcohol dependence	0.00152	0.00363	CcSEcCtD
Lithium—Loss of consciousness—Acamprosate—alcohol dependence	0.00151	0.00362	CcSEcCtD
Lithium—Muscular weakness—Citalopram—alcohol dependence	0.00151	0.00362	CcSEcCtD
Lithium—Agitation—Naltrexone—alcohol dependence	0.0015	0.00358	CcSEcCtD
Lithium—Convulsion—Acamprosate—alcohol dependence	0.00149	0.00357	CcSEcCtD
Lithium—Angioedema—Naltrexone—alcohol dependence	0.00149	0.00356	CcSEcCtD
Lithium—GSK3B—BDNF signaling pathway—GRIN2B—alcohol dependence	0.00147	0.00662	CbGpPWpGaD
Lithium—Arthralgia—Acamprosate—alcohol dependence	0.00147	0.00351	CcSEcCtD
Lithium—GSK3B—BDNF signaling pathway—CNR1—alcohol dependence	0.00146	0.00657	CbGpPWpGaD
Lithium—Syncope—Naltrexone—alcohol dependence	0.00146	0.00349	CcSEcCtD
Lithium—Discomfort—Acamprosate—alcohol dependence	0.00145	0.00346	CcSEcCtD
Lithium—Dry mouth—Acamprosate—alcohol dependence	0.00143	0.00343	CcSEcCtD
Lithium—Loss of consciousness—Naltrexone—alcohol dependence	0.00143	0.00342	CcSEcCtD
Lithium—Confusional state—Acamprosate—alcohol dependence	0.00142	0.00339	CcSEcCtD
Lithium—Convulsion—Naltrexone—alcohol dependence	0.00141	0.00338	CcSEcCtD
Lithium—IMPA1—Metabolism—ADH1B—alcohol dependence	0.00141	0.00634	CbGpPWpGaD
Lithium—Arthralgia—Naltrexone—alcohol dependence	0.00139	0.00332	CcSEcCtD
Lithium—Shock—Acamprosate—alcohol dependence	0.00138	0.00331	CcSEcCtD
Lithium—Discomfort—Naltrexone—alcohol dependence	0.00137	0.00328	CcSEcCtD
Lithium—Erectile dysfunction—Citalopram—alcohol dependence	0.00136	0.00326	CcSEcCtD
Lithium—GRIA3—Neuronal System—MAOA—alcohol dependence	0.00136	0.00613	CbGpPWpGaD
Lithium—Dry mouth—Naltrexone—alcohol dependence	0.00136	0.00324	CcSEcCtD
Lithium—Weight increased—Citalopram—alcohol dependence	0.00135	0.00322	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—CRH—alcohol dependence	0.00134	0.00603	CbGpPWpGaD
Lithium—Confusional state—Naltrexone—alcohol dependence	0.00134	0.00321	CcSEcCtD
Lithium—Weight decreased—Citalopram—alcohol dependence	0.00134	0.00321	CcSEcCtD
Lithium—Anorexia—Acamprosate—alcohol dependence	0.00134	0.0032	CcSEcCtD
Lithium—Hyperglycaemia—Citalopram—alcohol dependence	0.00134	0.0032	CcSEcCtD
Lithium—Oedema—Naltrexone—alcohol dependence	0.00133	0.00318	CcSEcCtD
Lithium—Hypotension—Acamprosate—alcohol dependence	0.00131	0.00314	CcSEcCtD
Lithium—IMPA2—Metabolism—MAOB—alcohol dependence	0.00131	0.00589	CbGpPWpGaD
Lithium—Shock—Naltrexone—alcohol dependence	0.00131	0.00313	CcSEcCtD
Lithium—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00128	0.00306	CcSEcCtD
Lithium—Anorexia—Naltrexone—alcohol dependence	0.00127	0.00303	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—POMC—alcohol dependence	0.00125	0.00563	CbGpPWpGaD
Lithium—Somnolence—Acamprosate—alcohol dependence	0.00125	0.00299	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—SLC6A4—alcohol dependence	0.00125	0.00561	CbGpPWpGaD
Lithium—Dyspepsia—Acamprosate—alcohol dependence	0.00124	0.00296	CcSEcCtD
Lithium—Decreased appetite—Acamprosate—alcohol dependence	0.00122	0.00292	CcSEcCtD
Lithium—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00121	0.0029	CcSEcCtD
Lithium—Bradycardia—Citalopram—alcohol dependence	0.00121	0.00289	CcSEcCtD
Lithium—Somnolence—Naltrexone—alcohol dependence	0.00118	0.00283	CcSEcCtD
Lithium—Hallucination—Citalopram—alcohol dependence	0.00118	0.00282	CcSEcCtD
Lithium—GSK3B—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.00118	0.00529	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—DRD4—alcohol dependence	0.00117	0.00527	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MAOB—alcohol dependence	0.00117	0.00525	CbGpPWpGaD
Lithium—GSK3B—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—alcohol dependence	0.00116	0.00521	CbGpPWpGaD
Lithium—Feeling abnormal—Acamprosate—alcohol dependence	0.00116	0.00277	CcSEcCtD
Lithium—Decreased appetite—Naltrexone—alcohol dependence	0.00116	0.00276	CcSEcCtD
Lithium—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00115	0.00275	CcSEcCtD
Lithium—Fatigue—Naltrexone—alcohol dependence	0.00115	0.00274	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—POMC—alcohol dependence	0.00114	0.00513	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ALDH2—alcohol dependence	0.00112	0.00501	CbGpPWpGaD
Lithium—Body temperature increased—Acamprosate—alcohol dependence	0.00111	0.00266	CcSEcCtD
Lithium—Abdominal pain—Acamprosate—alcohol dependence	0.00111	0.00266	CcSEcCtD
Lithium—Tinnitus—Citalopram—alcohol dependence	0.00111	0.00264	CcSEcCtD
Lithium—Feeling abnormal—Naltrexone—alcohol dependence	0.0011	0.00262	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—HTR7—alcohol dependence	0.00109	0.00491	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—DRD2—alcohol dependence	0.00109	0.00491	CbGpPWpGaD
Lithium—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00109	0.0026	CcSEcCtD
Lithium—GSK3B—p53 pathway—EP300—alcohol dependence	0.00108	0.00486	CbGpPWpGaD
Lithium—Arrhythmia—Citalopram—alcohol dependence	0.00106	0.00253	CcSEcCtD
Lithium—GSK3B—Notch Signaling Pathway—EP300—alcohol dependence	0.00105	0.00473	CbGpPWpGaD
Lithium—Body temperature increased—Naltrexone—alcohol dependence	0.00105	0.00251	CcSEcCtD
Lithium—Abdominal pain—Naltrexone—alcohol dependence	0.00105	0.00251	CcSEcCtD
Lithium—Alopecia—Citalopram—alcohol dependence	0.00105	0.00251	CcSEcCtD
Lithium—GSK3A—Innate Immune System—WASF2—alcohol dependence	0.00102	0.00458	CbGpPWpGaD
Lithium—Flatulence—Citalopram—alcohol dependence	0.00102	0.00243	CcSEcCtD
Lithium—Dysgeusia—Citalopram—alcohol dependence	0.00101	0.00242	CcSEcCtD
Lithium—Asthenia—Acamprosate—alcohol dependence	0.00101	0.00241	CcSEcCtD
Lithium—IMPA1—Metabolism—ALDH2—alcohol dependence	0.000994	0.00447	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—WASF1—alcohol dependence	0.000977	0.00439	CbGpPWpGaD
Lithium—Vision blurred—Citalopram—alcohol dependence	0.000973	0.00233	CcSEcCtD
Lithium—Tremor—Citalopram—alcohol dependence	0.000967	0.00231	CcSEcCtD
Lithium—Diarrhoea—Acamprosate—alcohol dependence	0.000962	0.0023	CcSEcCtD
Lithium—Asthenia—Naltrexone—alcohol dependence	0.000954	0.00228	CcSEcCtD
Lithium—Agitation—Citalopram—alcohol dependence	0.000949	0.00227	CcSEcCtD
Lithium—IMPA2—Metabolism—GOT2—alcohol dependence	0.000948	0.00426	CbGpPWpGaD
Lithium—Angioedema—Citalopram—alcohol dependence	0.000943	0.00226	CcSEcCtD
Lithium—Dizziness—Acamprosate—alcohol dependence	0.000929	0.00222	CcSEcCtD
Lithium—Vertigo—Citalopram—alcohol dependence	0.000927	0.00222	CcSEcCtD
Lithium—Syncope—Citalopram—alcohol dependence	0.000926	0.00221	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—AVP—alcohol dependence	0.00092	0.00413	CbGpPWpGaD
Lithium—Diarrhoea—Naltrexone—alcohol dependence	0.00091	0.00218	CcSEcCtD
Lithium—Loss of consciousness—Citalopram—alcohol dependence	0.000907	0.00217	CcSEcCtD
Lithium—Convulsion—Citalopram—alcohol dependence	0.000894	0.00214	CcSEcCtD
Lithium—Vomiting—Acamprosate—alcohol dependence	0.000894	0.00214	CcSEcCtD
Lithium—IMPA2—Metabolism—CYP2E1—alcohol dependence	0.000891	0.00401	CbGpPWpGaD
Lithium—Rash—Acamprosate—alcohol dependence	0.000886	0.00212	CcSEcCtD
Lithium—Dermatitis—Acamprosate—alcohol dependence	0.000885	0.00212	CcSEcCtD
Lithium—Headache—Acamprosate—alcohol dependence	0.00088	0.00211	CcSEcCtD
Lithium—Dizziness—Naltrexone—alcohol dependence	0.000879	0.0021	CcSEcCtD
Lithium—Arthralgia—Citalopram—alcohol dependence	0.000879	0.0021	CcSEcCtD
Lithium—Discomfort—Citalopram—alcohol dependence	0.000868	0.00208	CcSEcCtD
Lithium—Dry mouth—Citalopram—alcohol dependence	0.00086	0.00206	CcSEcCtD
Lithium—Confusional state—Citalopram—alcohol dependence	0.00085	0.00203	CcSEcCtD
Lithium—Vomiting—Naltrexone—alcohol dependence	0.000845	0.00202	CcSEcCtD
Lithium—IMPA1—Metabolism—GOT2—alcohol dependence	0.000845	0.0038	CbGpPWpGaD
Lithium—Oedema—Citalopram—alcohol dependence	0.000843	0.00201	CcSEcCtD
Lithium—Rash—Naltrexone—alcohol dependence	0.000838	0.002	CcSEcCtD
Lithium—Dermatitis—Naltrexone—alcohol dependence	0.000838	0.002	CcSEcCtD
Lithium—Nausea—Acamprosate—alcohol dependence	0.000835	0.002	CcSEcCtD
Lithium—Headache—Naltrexone—alcohol dependence	0.000833	0.00199	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—EP300—alcohol dependence	0.000831	0.00373	CbGpPWpGaD
Lithium—Shock—Citalopram—alcohol dependence	0.000829	0.00198	CcSEcCtD
Lithium—IMPA2—Metabolism—GGT1—alcohol dependence	0.000818	0.00368	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GOT1—alcohol dependence	0.000818	0.00368	CbGpPWpGaD
Lithium—Anorexia—Citalopram—alcohol dependence	0.000803	0.00192	CcSEcCtD
Lithium—IMPA1—Metabolism—CYP2E1—alcohol dependence	0.000795	0.00357	CbGpPWpGaD
Lithium—Nausea—Naltrexone—alcohol dependence	0.00079	0.00189	CcSEcCtD
Lithium—Hypotension—Citalopram—alcohol dependence	0.000787	0.00188	CcSEcCtD
Lithium—GSK3B—Androgen receptor signaling pathway—EP300—alcohol dependence	0.000778	0.0035	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—GRIN2B—alcohol dependence	0.00077	0.00346	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000768	0.00184	CcSEcCtD
Lithium—GSK3B—Innate Immune System—WASF2—alcohol dependence	0.000753	0.00338	CbGpPWpGaD
Lithium—Somnolence—Citalopram—alcohol dependence	0.000749	0.00179	CcSEcCtD
Lithium—Dyspepsia—Citalopram—alcohol dependence	0.000742	0.00177	CcSEcCtD
Lithium—IMPA2—Metabolism—MAOA—alcohol dependence	0.000733	0.0033	CbGpPWpGaD
Lithium—Decreased appetite—Citalopram—alcohol dependence	0.000732	0.00175	CcSEcCtD
Lithium—IMPA1—Metabolism—GGT1—alcohol dependence	0.00073	0.00328	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GOT1—alcohol dependence	0.00073	0.00328	CbGpPWpGaD
Lithium—Fatigue—Citalopram—alcohol dependence	0.000726	0.00174	CcSEcCtD
Lithium—GSK3B—Innate Immune System—WASF1—alcohol dependence	0.000722	0.00324	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—EP300—alcohol dependence	0.000698	0.00314	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—EP300—alcohol dependence	0.000698	0.00314	CbGpPWpGaD
Lithium—Feeling abnormal—Citalopram—alcohol dependence	0.000694	0.00166	CcSEcCtD
Lithium—GSK3A—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.00069	0.0031	CbGpPWpGaD
Lithium—Gastrointestinal pain—Citalopram—alcohol dependence	0.000689	0.00165	CcSEcCtD
Lithium—Abdominal pain—Citalopram—alcohol dependence	0.000666	0.00159	CcSEcCtD
Lithium—Body temperature increased—Citalopram—alcohol dependence	0.000666	0.00159	CcSEcCtD
Lithium—IMPA1—Metabolism—MAOA—alcohol dependence	0.000654	0.00294	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—OPRK1—alcohol dependence	0.000641	0.00288	CbGpPWpGaD
Lithium—Asthenia—Citalopram—alcohol dependence	0.000604	0.00145	CcSEcCtD
Lithium—GSK3A—Immune System—WASF2—alcohol dependence	0.000594	0.00267	CbGpPWpGaD
Lithium—Diarrhoea—Citalopram—alcohol dependence	0.000576	0.00138	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000572	0.00257	CbGpPWpGaD
Lithium—GSK3A—Immune System—WASF1—alcohol dependence	0.000569	0.00256	CbGpPWpGaD
Lithium—Dizziness—Citalopram—alcohol dependence	0.000557	0.00133	CcSEcCtD
Lithium—GSK3B—Developmental Biology—GRIN2B—alcohol dependence	0.00055	0.00247	CbGpPWpGaD
Lithium—Vomiting—Citalopram—alcohol dependence	0.000536	0.00128	CcSEcCtD
Lithium—Rash—Citalopram—alcohol dependence	0.000531	0.00127	CcSEcCtD
Lithium—Dermatitis—Citalopram—alcohol dependence	0.000531	0.00127	CcSEcCtD
Lithium—Headache—Citalopram—alcohol dependence	0.000528	0.00126	CcSEcCtD
Lithium—Nausea—Citalopram—alcohol dependence	0.0005	0.0012	CcSEcCtD
Lithium—IMPA2—Metabolism—POMC—alcohol dependence	0.000478	0.00215	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—OPRK1—alcohol dependence	0.000473	0.00213	CbGpPWpGaD
Lithium—GSK3B—Immune System—WASF2—alcohol dependence	0.000439	0.00197	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—OPRD1—alcohol dependence	0.000431	0.00194	CbGpPWpGaD
Lithium—IMPA1—Metabolism—POMC—alcohol dependence	0.000426	0.00191	CbGpPWpGaD
Lithium—GSK3B—Immune System—WASF1—alcohol dependence	0.000421	0.00189	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PDYN—alcohol dependence	0.000413	0.00186	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—EP300—alcohol dependence	0.000405	0.00182	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CRHR1—alcohol dependence	0.000384	0.00172	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WASF2—alcohol dependence	0.000384	0.00172	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—EP300—alcohol dependence	0.00038	0.00171	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT2—alcohol dependence	0.00038	0.00171	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WASF1—alcohol dependence	0.000368	0.00165	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—EP300—alcohol dependence	0.000368	0.00165	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CHRM2—alcohol dependence	0.000361	0.00162	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—EP300—alcohol dependence	0.000342	0.00154	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—OPRM1—alcohol dependence	0.000331	0.00149	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT1—alcohol dependence	0.000328	0.00147	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—EP300—alcohol dependence	0.000326	0.00147	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—OPRD1—alcohol dependence	0.000318	0.00143	CbGpPWpGaD
Lithium—IMPA2—Metabolism—EP300—alcohol dependence	0.000317	0.00142	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—POMC—alcohol dependence	0.000311	0.0014	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDYN—alcohol dependence	0.000305	0.00137	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NPY—alcohol dependence	0.000305	0.00137	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CRH—alcohol dependence	0.000294	0.00132	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR1B—alcohol dependence	0.000294	0.00132	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WASF2—alcohol dependence	0.000284	0.00127	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CRHR1—alcohol dependence	0.000284	0.00127	CbGpPWpGaD
Lithium—IMPA1—Metabolism—EP300—alcohol dependence	0.000282	0.00127	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—EP300—alcohol dependence	0.000282	0.00127	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT2—alcohol dependence	0.000281	0.00126	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WASF1—alcohol dependence	0.000272	0.00122	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CHRM2—alcohol dependence	0.000267	0.0012	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD4—alcohol dependence	0.000257	0.00116	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CNR1—alcohol dependence	0.000246	0.0011	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—OPRM1—alcohol dependence	0.000245	0.0011	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT1—alcohol dependence	0.000242	0.00109	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD2—alcohol dependence	0.00024	0.00108	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR7—alcohol dependence	0.00024	0.00108	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—EP300—alcohol dependence	0.000236	0.00106	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPY—alcohol dependence	0.000225	0.00101	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1B—alcohol dependence	0.000217	0.000977	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CRH—alcohol dependence	0.000217	0.000977	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AVP—alcohol dependence	0.000202	0.000906	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EP300—alcohol dependence	0.000197	0.000887	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD4—alcohol dependence	0.00019	0.000854	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CNR1—alcohol dependence	0.000181	0.000815	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD2—alcohol dependence	0.000177	0.000795	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR7—alcohol dependence	0.000177	0.000795	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EP300—alcohol dependence	0.000174	0.000784	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—alcohol dependence	0.000168	0.000754	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AVP—alcohol dependence	0.000149	0.00067	CbGpPWpGaD
Lithium—GSK3A—Immune System—EP300—alcohol dependence	0.000137	0.000618	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—alcohol dependence	0.000134	0.000602	CbGpPWpGaD
Lithium—GSK3A—Disease—EP300—alcohol dependence	0.000127	0.00057	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—alcohol dependence	0.000124	0.000557	CbGpPWpGaD
Lithium—GSK3B—Immune System—EP300—alcohol dependence	0.000102	0.000456	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—alcohol dependence	9.9e-05	0.000445	CbGpPWpGaD
Lithium—GSK3B—Disease—EP300—alcohol dependence	9.38e-05	0.000421	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EP300—alcohol dependence	8.89e-05	0.000399	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EP300—alcohol dependence	6.57e-05	0.000295	CbGpPWpGaD
